Search

everythinglearnresearchcommunity

for

Search:↓

Special cells can help regrow hair in alopecia areata.

TLR3 activation helps improve skin and hair follicle healing in mice.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Type 3C diabetes is a distinct condition needing more research and treatment strategies.

Targeting specific T cells may help treat alopecia areata.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Transglutaminase-3 is often reduced in esophageal cancer.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Tislelizumab can cause cutaneous lupus erythematosus.

CD34 is crucial for skin tumor development in mice.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

γδ T cells adapt uniquely to different tissues in mice.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.